Your Goals.
Your Body.
Your Collection.
Designed for Every Body, Tailored to You
Our peptide and metabolic therapy line supports weight loss, body composition, and metabolic health through a range of options. These therapies work through complementary approaches, including appetite and metabolic regulation, targeted fat reduction, and support for fat metabolism, all tailored to individual goals.
Featured Products
A dual GIP/GLP-1 receptor agonist designed to support meaningful weight loss and metabolic health. Tirzepatide helps regulate appetite, improve insulin sensitivity, and support sustainable fat loss as part of a medically supervised program.
A dual GIP/GLP-1 receptor agonist designed to support meaningful weight loss and metabolic health. Tirzepatide helps regulate appetite, improve insulin sensitivity, and support sustainable fat loss as part of a medically supervised program.
A dual GIP/GLP-1 receptor agonist designed to support meaningful weight loss and metabolic health. Tirzepatide helps regulate appetite, improve insulin sensitivity, and support sustainable fat loss as part of a medically supervised program.
A growth hormone-releasing factor analog studied for its effects on visceral fat reduction and body composition, with applications in hormonal optimization programs.
A blend of lipotropic compounds (such as choline, inositol, and methionine) formulated to support fat metabolism and liver function, often paired with broader weight management protocols.
A next-generation triple-agonist peptide (GIP/GLP-1/glucagon) currently studied for its potential to support more advanced weight management outcomes than earlier-generation therapies.
A next-generation triple-agonist peptide (GIP/GLP-1/glucagon) currently studied for its potential to support more advanced weight management outcomes than earlier-generation therapies.
A modified fragment of human growth hormone studied for its potential role in targeting stubborn, localized fat without the broader metabolic effects of full-length HGH. Used as part of a personalized body composition plan.
A long-acting amylin analog studied for its appetite-regulating effects, frequently discussed alongside GLP-1 therapies for combined appetite control and metabolic support.